Compound ID | 2116
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Fatty acid synthesis inhibitor. Binds to FabB and FabF; FabB/ FabF inhibitor |
| Target Pathogen: | Active against E. coli |
| Description: | Natural product produced by Streptomyces and Nocardia; total synthesis, several analogues; researched for anticancer treatment |
| Year first mentioned: | 1981 |
| Development status: | Experimental |